• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

D-乳酸酸中毒——病例报告及文献综述

D-lactic acidosis - case report and review of the literature.

作者信息

Fabian Elisabeth, Kramer Ludwig, Siebert Franz, Högenauer Christoph, Raggam Reinhard Bernd, Wenzl Heimo, Krejs Guenter J

机构信息

Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Austria.

1st Department of Internal Medicine with Gastroenterology, Hietzing Hospital, Vienna, Austria.

出版信息

Z Gastroenterol. 2017 Jan;55(1):75-82. doi: 10.1055/s-0042-117647. Epub 2016 Oct 10.

DOI:10.1055/s-0042-117647
PMID:27723911
Abstract

D-lactic acidosis is a rare complication that occurs mainly in patients with malabsorption due to a surgically altered gastrointestinal tract anatomy, namely in short bowel syndrome or after bariatric surgery. It is characterized by rapid development of neurological symptoms and severe metabolic acidosis, often with a high serum anion gap. Malabsorbed carbohydrates can be fermented by colonic microbiota capable of producing D-lactic acid. Routine clinical assessment of serum lactate covers only L-lactic acid; when clinical suspicion for D-lactic acidosis is high, special assays for D-lactic acid are called for. A serum level of more than 3 mmol/L of D-lactate confirms the diagnosis. Management includes correction of metabolic acidosis by intravenous bicarbonate, restriction of carbohydrates or fasting, and antibiotics to eliminate intestinal bacteria that produce D-lactic acid. We report a case of D-lactic acidosis in a patient with short bowel syndrome and review the pathophysiology of D-lactic acidosis with its biochemical and clinical features. D-lactic acidosis should be considered when patients with short bowel syndrome or other malabsorption syndromes due to an altered gastrointestinal tract anatomy present with metabolic acidosis and neurological symptoms that cannot be attributed to other causes. With the growing popularity of bariatric surgery, this metabolic derangement may be seen more frequently in the future.

摘要

D-乳酸酸中毒是一种罕见的并发症,主要发生于因胃肠道解剖结构手术改变导致吸收不良的患者,即短肠综合征患者或减肥手术后的患者。其特征为神经症状迅速发展以及严重的代谢性酸中毒,通常伴有高血清阴离子间隙。吸收不良的碳水化合物可被能够产生D-乳酸的结肠微生物群发酵。血清乳酸的常规临床检测仅涵盖L-乳酸;当对D-乳酸酸中毒的临床怀疑度较高时,需要进行D-乳酸的特殊检测。血清D-乳酸水平超过3 mmol/L可确诊。治疗包括静脉输注碳酸氢盐纠正代谢性酸中毒、限制碳水化合物摄入或禁食,以及使用抗生素消除产生D-乳酸的肠道细菌。我们报告一例短肠综合征患者发生D-乳酸酸中毒的病例,并回顾D-乳酸酸中毒的病理生理学及其生化和临床特征。当短肠综合征患者或因胃肠道解剖结构改变导致的其他吸收不良综合征患者出现代谢性酸中毒和无法归因于其他原因的神经症状时,应考虑D-乳酸酸中毒。随着减肥手术越来越普及,这种代谢紊乱在未来可能会更频繁地出现。

相似文献

1
D-lactic acidosis - case report and review of the literature.D-乳酸酸中毒——病例报告及文献综述
Z Gastroenterol. 2017 Jan;55(1):75-82. doi: 10.1055/s-0042-117647. Epub 2016 Oct 10.
2
Recurrent D-lactic acidosis in a child with short bowel syndrome.一名短肠综合征患儿的复发性D-乳酸酸中毒
Asia Pac J Clin Nutr. 2005;14(2):195-8.
3
D-lactic acidosis secondary to short bowel syndrome.短肠综合征继发的D-乳酸酸中毒
Postgrad Med J. 2003 Feb;79(928):110-2. doi: 10.1136/pmj.79.928.110.
4
D-lactic acidosis in short-bowel syndrome managed with antibiotics and probiotics.使用抗生素和益生菌治疗短肠综合征中的D-乳酸酸中毒。
J Pediatr Surg. 2004 Apr;39(4):634-6. doi: 10.1016/j.jpedsurg.2003.12.026.
5
[D-lactic acidosis in a child with short bowel syndrome].[一名短肠综合征患儿的D-乳酸酸中毒]
Arch Pediatr. 2008 Feb;15(2):145-8. doi: 10.1016/j.arcped.2007.11.009. Epub 2008 Feb 1.
6
D-lactic acidosis. A review of clinical presentation, biochemical features, and pathophysiologic mechanisms.D-乳酸酸中毒。临床表现、生化特征及病理生理机制综述。
Medicine (Baltimore). 1998 Mar;77(2):73-82. doi: 10.1097/00005792-199803000-00001.
7
D-Lactic acidosis 25 years after bariatric surgery due to Salmonella enteritidis.肠杆菌性食物中毒导致减重手术后 25 年发生 D-乳酸酸中毒
Nutrition. 2012 Jan;28(1):108-11. doi: 10.1016/j.nut.2011.07.005. Epub 2011 Oct 12.
8
D-lactic acidosis in short bowel syndrome.短肠综合征中的D-乳酸酸中毒
N Z Med J. 1999 Jul 23;112(1092):277-8.
9
[D-lactic acidosis - a rare complication of short bowel syndrome].[D-乳酸酸中毒——短肠综合征的一种罕见并发症]
Vnitr Lek. 2021 Winter;67(E-5):28-33.
10
[D-lactic acidosis in an 11-year-old patient with short bowel syndrome].[一名11岁短肠综合征患者的D-乳酸酸中毒]
An Pediatr (Barc). 2006 Apr;64(4):385-7. doi: 10.1157/13086529.

引用本文的文献

1
L- and D-Lactate: unveiling their hidden functions in disease and health.L-乳酸和D-乳酸:揭示它们在疾病与健康中的潜在功能
Cell Commun Signal. 2025 Mar 12;23(1):134. doi: 10.1186/s12964-025-02132-z.
2
Metabolic acidosis due to d-lactate in a patient with intestinal resection: Diagnostic challenges and nutritional strategies.肠切除患者因d-乳酸导致的代谢性酸中毒:诊断挑战与营养策略
Int J Surg Case Rep. 2025 Jan;126:110801. doi: 10.1016/j.ijscr.2024.110801. Epub 2024 Dec 28.
3
Microbiota derived D-malate inhibits skeletal muscle growth and angiogenesis during aging via acetylation of Cyclin A.
肠道菌群衍生的 D-苹果酸通过乙酰化细胞周期蛋白 A 抑制衰老过程中的骨骼肌生长和血管生成。
EMBO Rep. 2024 Feb;25(2):524-543. doi: 10.1038/s44319-023-00028-y. Epub 2024 Jan 22.
4
Lactate dehydrogenase D is a general dehydrogenase for D-2-hydroxyacids and is associated with D-lactic acidosis.乳酸脱氢酶 D 是一种 D-2-羟基酸的通用脱氢酶,与 D-乳酸酸中毒有关。
Nat Commun. 2023 Oct 20;14(1):6638. doi: 10.1038/s41467-023-42456-3.
5
Dual Role of Probiotic Lactic Acid Bacteria Cultures for Fermentation and Control Pathogenic Bacteria in Fruit-Enriched Fermented Milk.富含水果的发酵乳中益生菌乳酸菌培养物在发酵和控制病原菌方面的双重作用。
Probiotics Antimicrob Proteins. 2024 Oct;16(5):1801-1816. doi: 10.1007/s12602-023-10135-w. Epub 2023 Aug 12.
6
D-Lactate: Implications for Gastrointestinal Diseases.D-乳酸:对胃肠疾病的影响
Children (Basel). 2023 May 26;10(6):945. doi: 10.3390/children10060945.
7
Emerging issues in probiotic safety: 2023 perspectives.益生菌安全性的新问题:2023 年的观点。
Gut Microbes. 2023 Jan-Dec;15(1):2185034. doi: 10.1080/19490976.2023.2185034.
8
Lactic Acidosis Related to Pharmacotherapy and Human Diseases.与药物治疗及人类疾病相关的乳酸性酸中毒
Pharmaceuticals (Basel). 2022 Nov 30;15(12):1496. doi: 10.3390/ph15121496.
9
Considerations for determining safety of probiotics: A USP perspective.确定益生菌安全性的考虑因素:USP 的观点。
Regul Toxicol Pharmacol. 2022 Dec;136:105266. doi: 10.1016/j.yrtph.2022.105266. Epub 2022 Oct 4.
10
Metabolite discovery: Biochemistry's scientific driver.代谢物发现:生物化学的科学驱动力。
Cell Metab. 2022 Jan 4;34(1):21-34. doi: 10.1016/j.cmet.2021.11.005.